Develops drugs to treat ALS and other brain diseases.
No change
Greenlight owns 2.3 million shares of Coya Therapeutics, worth about $14 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
2,335,540
Jun 30
2,335,540
The numbers
Shares they own
2,335,540
Value on Jun 30, 2026
$13,662,909
about $14 million
Share of their money
0.3%
less than $1 of every $100 · 42nd of 46
Price per share on Jun 30
$5.85
Kind
Shares
Also owned by
No other fund we follow
More about Coya Therapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.